How many insider trades does FilingIQ track for SABS?

FilingIQ tracks 65 Form 4 insider transactions for SABS (SAB Biotherapeutics, Inc.), covering filings from Sep 28, 2021 onwards. 1 of those were filed in the last 90 days.

Are SABS insiders net buyers or net sellers?

Across the full Form 4 history for SABS, 5 transactions (8%) were open-market purchases and 1 (2%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.

Where does SABS insider data come from?

Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.

What sector is SABS in?

SAB Biotherapeutics, Inc. (SABS) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $169.00M.

SABS insider trading

Healthcare

SAB Biotherapeutics, Inc. — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.

Total Form 4 trades

Last 90 days

Buys / sells

8% / 2%

Market cap

$169.00M

About SAB Biotherapeutics, Inc.

SAB Biotherapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of human polyclonal immunotherapeutic antibodies to address immune system disorders. It has applied advanced genetic engineering to develop transchromosomic for hyperimmunization and plasma collection, as well as develops product to treat diseases, including type 1 diabetes (T1D) and other autoimmune disorders. In addition, its lead product candidate SAB-142, a human, multi-target anti-thymocyte globulin treatment, currently under Phase 2b clinical trials in delaying the onset or progression of type 1. SAB Biotherapeutics, Inc. was founded in 2014 and is headquartered in Miami Beach, Florida.

Company website: www.sabbiotherapeutics.com

SABS insider activity at a glance

FilingIQ has scored 65 insider transactions for SABS since Sep 28, 2021. The most recent filing in our index is dated Mar 24, 2026.

Across the full history, 5 open-market purchases and 1 open-market sales were filed under transaction codes P and S respectively. Compensatory share awards (code A) and option exercises (code M) are tracked separately and not counted here.

The average FilingIQ composite score on SABS insider trades is 63.8/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.

View live SABS trades on FilingIQ Raw filings on SEC EDGAR

Latest SABS Form 4 filings

King Michael CHIEF FINANCIAL OFFICER

P Nov 30, 2023

Most recent disclosures. Sign up to filter by score, transaction code, or insider role.

Other Healthcare tickers with recent insider activity

UTHR 1,098

UNITED THERAPEUTICS Corp

APLS 279

Apellis Pharmaceuticals, Inc.

KMDA 218

KAMADA LTD

BMY 185

BRISTOL MYERS SQUIBB CO

ADPT 184

Adaptive Biotechnologies Corp

GH 169

Guardant Health, Inc.

ISRG 166

INTUITIVE SURGICAL INC

VTRS 165

Viatris Inc

Frequently asked

How many insider trades does FilingIQ track for SABS?: FilingIQ tracks 65 Form 4 insider transactions for SABS (SAB Biotherapeutics, Inc.), covering filings from Sep 28, 2021 onwards. 1 of those were filed in the last 90 days.
Are SABS insiders net buyers or net sellers?: Across the full Form 4 history for SABS, 5 transactions (8%) were open-market purchases and 1 (2%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
Where does SABS insider data come from?: Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
What sector is SABS in?: SAB Biotherapeutics, Inc. (SABS) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $169.00M.

Methodology & sources

Every SABS insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.